Publications
14
Citations
35
Est. group size
~14
Recurring co-author estimate
Active years
6
Publishing since 2021
Alexander Rudich's research focuses on blood cancers, particularly leukemia and lymphoma, including how these diseases are diagnosed, treated, and why some cases resist therapy. Recent work has examined non-coding RNAs (a type of genetic material that regulates genes without producing proteins) as a factor in drug resistance in chronic myeloid leukemia. The publication record indicates a growing focus on hematology and cancer biomarker research in recent years.
Publication output was minimal or absent from 2017-2020, then increased steadily from 2021 onward, with a notable rise in output during 2023-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance
International Journal of Molecular Sciences · 2022
- Journal of the National Comprehensive Cancer Network×3
- Experimental Hematology×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- International Journal of Molecular Sciences×1
- Leukemia×1
- Malith Karunasiri
Medicine · The Ohio State University
- Gabriela Sanchez‐Petitto
Medicine · The Ohio State University
- James Ropa
Medicine · Indiana University
- Karilyn Larkin
Medicine · The Ohio State University
- Marcos J.G. De Lima
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile